Screening Tool of Older Person's Prescriptions

Screening Tools to Alert Doctors to Right Treatment Medication Criteria Modified for U.S. Nursing Home Setting

Published in: Journal of American Geriatrics Society, [Epub December 2016], doi 10.1111/jgs.14689

Posted on RAND.org on March 15, 2017

by Dmitry Khodyakov, Aileen Ochoa, Brianne L. Olivieri-Mui, Carla Bouwmeester, Barbara Zarowitz, Meenakshi Patel, Diana Ching, Becky Briesacher

Read More

Access further information on this document at Published in: Journal of American Geriatrics Society

This article was published outside of RAND. The full text of the article can be found at the link above.

Objectives

To develop a set of prescribing indicators measurable with available data from electronic nursing home (NH) databases by adapting the European-based 2014 Screening Tool of Older Person's Prescriptions (STOPP) and Screening Tools to Alert Doctors to Right Treatment (START) criteria of potentially inappropriate and underused medications for the U.S.

Design

A two-stage expert panel process. In the first stage, the investigator team reviewed 114 criteria for compatibility and measurability. In the second stage, an online modified e-Delphi (OMD) panel was convened to rate the validity of criteria, and two webinars were held to identify criteria with highest relevance to U.S. NHs.

Participants

Seventeen experts with recognized reputations in NH care participated in the e-Delphi panel and 12 in the webinar.

Measurements

Compatibility and measurability were assessed by comparing criteria with U.S. terminology and setting standards and data elements in NH databases. Validity was rated using a 9-point Likert-type scale (1 = not valid at all, 9 = highly valid). Mean, median, interpercentile ranges, and agreement were determined for each criterion score. Relevance was determined by ranking the mean panel ratings on criteria that reached agreement; the webinar participants reviewed and approved half of the criteria with the highest mean values.

Results

Fifty-three STOPP/START criteria were deemed to be compatible with the U.S. NH setting and measurable using data from electronic NH databases. E-Delphi panelists rated 48 criteria as valid for U.S. NHs. Twenty-four criteria were deemed to be most relevant, consisting of 22 measures of potentially inappropriate medications and two measures of underused medications.

Conclusion

This study created the first explicit criteria for assessing the quality of prescribing in U.S. NHs.

This report is part of the RAND Corporation external publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.